Podcast Episodes

Back to Search
Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval
Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval

In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Card…

2 years, 3 months ago

Short Long
View Episode
CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval
CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA appr…

2 years, 4 months ago

Short Long
View Episode
Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system
Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system

In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acq…

2 years, 4 months ago

Short Long
View Episode
CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy
CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiother…

2 years, 4 months ago

Short Long
View Episode
Hologic's FDA-cleared Genius Digital Dx Systems leads AI innovation in cervical cancer prevention
Hologic's FDA-cleared Genius Digital Dx Systems leads AI innovation in cervical cancer prevention

In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics. In our keynote int…

2 years, 4 months ago

Short Long
View Episode
Mullings and Bell unpack SRS 2024: Surprises, disappointments and where is surgical robotics headed?
Mullings and Bell unpack SRS 2024: Surprises, disappointments and where is surgical robotics headed?

In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry expert…

2 years, 4 months ago

Short Long
View Episode
Boston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of history
Boston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of history

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s i…

2 years, 4 months ago

Short Long
View Episode
CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device
CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details …

2 years, 5 months ago

Short Long
View Episode
Asensus Surgical on reshaping robotic surgery with augmented intelligence; AWS's purpose-built AI
Asensus Surgical on reshaping robotic surgery with augmented intelligence; AWS's purpose-built AI

In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between…

2 years, 5 months ago

Short Long
View Episode
OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting
OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting

In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interview…

2 years, 5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us